How Common Sweeteners Directly Alter Your Gut Bacteria

Artificial and low-calorie sweeteners are present in thousands of everyday products — soft drinks, yoghurts, breakfast cereals, protein bars, and even medications. They are widely assumed to pass through the body without interacting with the trillions of bacteria living in the digestive tract. A new study from the University of Cambridge shows that assumption is wrong.

39 sweeteners, 25 bacterial species, one clear pattern

Researchers at the MRC Toxicology Unit at Cambridge grew 25 different bacterial species commonly found in the human gut, representing beneficial, neutral, and potentially harmful microbes. Each species was exposed separately to 39 commercially used sweeteners, including both natural varieties like steviol glycosides and artificial ones such as aspartame, sucralose, and saccharin. The team measured how quickly each bacterial culture multiplied and whether its growth slowed or stopped.

The result: roughly three-quarters of the sweeteners directly affected the growth of at least one bacterial species. Several significantly reduced or completely halted the growth of bacteria associated with digestive health, blood sugar regulation, and immune function. The effect was not limited to artificial compounds — some natural sweeteners also altered bacterial behaviour.

The isosteviol-duloxetine combination

The strongest disruption occurred when researchers combined isosteviol, a sweetener derived from the stevia plant and used widely in the food and beverage industry, with duloxetine, a common antidepressant. Together, the two compounds sharply reduced the growth of two important bacterial species that are associated with digestive health and metabolic regulation. The finding is particularly significant because it shows that sweeteners do not act in isolation — their effects change depending on what else is consumed at the same time.

More than 100 hidden interactions

People rarely consume a sweetener on its own. A diet soda combines it with caffeine; a dessert may include vanillin and other flavourings; a medication may pair a sweetener with an active pharmaceutical ingredient. To capture this real-world complexity, the researchers paired each sweetener with caffeine, vanillin, advantame (another sweetener), and eight commonly prescribed drugs. They identified more than 100 cases where a sweetener's effect on bacteria changed when another compound was present. In 34 cases the effect became stronger, and in 68 cases it became weaker or disappeared entirely.

This means that the impact of a particular sweetener on gut health may depend partly on what else is in the stomach at the same time — a variable that previous studies rarely accounted for.

Why the gut microbiome matters

The human gut microbiome is an enormous ecosystem of bacteria, fungi, and viruses that help break down food, produce essential vitamins, train the immune system, and regulate metabolism. Disruption of the microbiome has been linked to type 2 diabetes, obesity, inflammatory bowel disease, and even neurological conditions. The Cambridge study does not prove that sweetener-induced bacterial changes cause these diseases — the experiments were conducted in the laboratory, not in living humans — but it provides a clear biological mechanism by which sweeteners could influence health.

Knowledge takeaway: sweeteners are not biologically inert — about 75% directly affect gut bacterial growth in laboratory testing; the effect changes dramatically when sweeteners are combined with medications, caffeine, or flavourings (over 100 interaction cases identified); the isosteviol-duloxetine combination was the most disruptive, sharply reducing two beneficial bacterial species; these findings provide a plausible biological pathway linking sweeteners to metabolic and immune health conditions, though human studies are needed to confirm real-world relevance.